A Randomized, Double-blind, Placebo-Controlled Study of Efficacy of Oral Acyclovir in the Treatment of Pityriasis Rosea
Open Access
- 1 January 2014
- journal article
- Published by JCDR Research and Publications in Journal of Clinical and Diagnostic Research
- Vol. 8 (5) , YC01-4
Abstract
Journal of Clinical and Diagnostic Research aims to publish findings of doctors at grass root level and post graduate students, so that all unique medical experiences are recorded in literature.Keywords
This publication has 21 references indexed in Scilit:
- Low dose of acyclovir may be an effective treatment against pityriasis rosea: a random investigator-blind clinical trial on 64 patientsJournal of the European Academy of Dermatology and Venereology, 2010
- Additional Evidence that Pityriasis Rosea Is Associated with Reactivation of Human Herpesvirus-6 and -7Journal of Investigative Dermatology, 2005
- Quality of Life in Children with Pityriasis Rosea: A Prospective Case Control StudyPediatric Dermatology, 2003
- Case Clustering in Pityriasis RoseaArchives of Dermatology, 2003
- Pityriasis Rosea is Associated with Systemic Active Infection with Both Human Herpesvirus-7 and Human Herpesvirus-6Journal of Investigative Dermatology, 2002
- Human herpes virus‐like particles in pityriasis rosea lesions: an electron microscopy studyJournal of Cutaneous Pathology, 2002
- Erythromycin in pityriasis rosea: A double-blind, placebo-controlled clinical trial☆, ☆☆Journal of the American Academy of Dermatology, 2000
- Pityriasis rosea-like eruption in a patient receiving omeprazolc syndromeBritish Journal of Dermatology, 1996
- Recent upper respiratory tract infection and pityriasis rosea: a case-control study of 249 matched pairsBritish Journal of Dermatology, 1983
- Pityriasis Rosea-like Drug Eruption Secondary to MetronidazoleArchives of Dermatology, 1977